Ind-Swift Laboratories Ltd

Overall Rating: star ratingstar ratingstar ratingstar ratingstar rating[0/5]Total Votes [  ]  
Rate this page:
Ind-Swift Laboratories Ltd - About the company

A division of the Ind-swift Group, Ind-Swift Laboratories was founded in the year 1995. This leading pharmaceutical company went public in the year 1997. Ind-Swift Limited in collaboration with Punjab State Industrial Development Corporation Limited (PSIDC) promoted the growth of this firm. Within few years of its establishment, Ind-Swift Laboratories Ltd has earned world wide recognition as well as a Bulk-Actives supplier in over 40 countries.

The company mainly bases its production in the creation of Active Pharmaceutical Ingredients or API. Besides, its involvement in organic synthetic chemistry has helped Ind-Swift Laboratories Ltd. to emerge as leader in the production of various products not only in the Indian subcontinent as well as throughout the world. The products manufactured by this company include capsule, oral solution, eye and ear drops, tablets, creams and gels. The products manufactured by Ind-Swift Laboratories Ltd are mainly used in the antiallergy, macrolide antibiotic, diabetology, antiulcerant, cardiovascular therapeutic sector.

The manufacturing plants of the company engage in the production of USFDA approved products. In addition, the company follows a long term policy in various regulated markets such as drugs which is worth US $80 billion, in order to maintain its quality production. The shares of Ind-Swift Laboratories Ltd. are listed on Bombay, Delhi, National and Ludhiana stock exchanges.

Ind-Swift Laboratories Ltd is also engaged in research and development, commonly known as R&D. The company involves in the research for advanced intermediates, non-infringing processes development for promising molecules, contract research, process optimization as well as improvement, contract manufacturing and many more.

Ind-Swift Laboratories Ltd - Management

The management details of Ind-Swift Laboratories Ltd are mentioned below:

  • Chairperson - S R Mehta

  • MD - N R Munjal

  • Chief Operating Officer - L K Wadhwa

  • Nominee Director - IFCI - S P Sharma

  • Joint Managing Director - Himanshu Jain

  • Independent Director - Pradeep Kumar

  • The members of the board of director of Ind-Swift Laboratories Ltd are

  • V R Mehta
  • G Munjal
  • J K Kakkar
  • K M S Nambiar
  • H P S Chawla
  • N D Aggarwal
  • Rishav Mehta


  • Ind-Swift Laboratories Ltd - Financial Statement

    The financial statement of Ind-Swift Laboratories Limited has been mentioned in the table below:

    Particulars March 31 2006 March 31 2007 March 31 2008 March 31 2009
    Total Revenues 3,145.4 3,531.0 4,577.8 5,902.0
    Gross Profit 901.7 980.6 1,248.6 1,645.1
    Operating Income 558.6 599.2 850.3 1,048.7
    Net Income 334.9 182.4 314.2 403.9


    Ind-Swift Laboratories Ltd - Products and Services

    The different products and services produced by Ind-Swift Laboratories Ltd are mentioned below:

  • Macrolide Antibiotics

  • Cardiovascular

  • Anti Histamine

  • Anti Diabetic

  • Analgesic

  • Aromatase Inhibtors

  • Anti Depressant

  • Anti Diarrheoal

  • Alcohol Absistence

  • Anti Parkinson

  • Anti Psychotic

  • Ind-Swift Laboratories Ltd - Contact Details
    Corporate Office:

    S.C.O. 850,
    Shivalik Enclave,
    Manimajra
    Chandigarh - 160101,
    India
    Phone: 91 172 2730503, 2730920, 5061850-53,
    5076458, 5086248,2738827,2738828,5072079,
    5072079, 3292003
    Fax: 91 172 2730504
    E mail: [email protected]



    Last updated on 6thJuly 2011